• In the media
  • Report spotlights drug firms' supply chain in...
Media - published on 28 Jan 2021

Report spotlights drug firms' supply chain initiatives, hurdles in LMICs

Liana Matt McLernon of the Center for Infectious Disease Research and Policy (CIDRAP) writes about the supply chain and manufacturing initiatives assessed in the 2021 Access to Medicine Index and the impact of the COVID-19 pandemic on supply chains, noting that access plans are still to be widely implemented.

Get in touch

Back to top |